Publications in collaboration with researchers from Hospital Universitario Central de Asturias (37)

2022

  1. Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

    Journal of Parkinson's Disease, Vol. 12, Núm. 3, pp. 935-955

  2. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group

    Journal of Parkinson's Disease, Vol. 12, Núm. 1, pp. 315-331

2021

  1. Staging Parkinson’s disease combining motor and nonmotor symptoms correlates with disability and quality of life

    Parkinson's Disease, Vol. 2021

  2. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

    Brain, Vol. 144, Núm. 9, pp. 2798-2811

  3. Predictors of loss of functional independence in parkinson’s disease: Results from the coppadis cohort at 2-year follow-up and comparison with a control group

    Diagnostics, Vol. 11, Núm. 10

  4. Predictors of global non-motor symptoms burden progression in parkinson’s disease. Results from the coppadis cohort at 2-year follow-up

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  5. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  6. Mood in Parkinson's disease: From early- to late-stage disease

    International journal of geriatric psychiatry, Vol. 36, Núm. 5, pp. 627-646

  7. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

  8. Diplopia is frequent and associated with motor and non-motor severity in parkinson’s disease: Results from the COPPADIS cohort at 2-year follow-up

    Diagnostics, Vol. 11, Núm. 12

2020

  1. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

  2. Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression

    Journal of the Neurological Sciences, Vol. 418

  3. Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Clinical and genetic characteristics of late-onset Huntington's disease

    Parkinsonism and Related Disorders, Vol. 61, pp. 101-105

  2. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

    European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407

2018

  1. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

    Journal of Huntington's Disease, Vol. 7, Núm. 3, pp. 209-222

2017

  1. Use of eltrombopag for secondary immune thrombocytopenia in clinical practice

    British Journal of Haematology, Vol. 178, Núm. 6, pp. 959-970

  2. Parkinson's disease severity at 3 years can be predicted from non-motor symptoms at baseline

    Frontiers in Neurology, Vol. 8, Núm. OCT

  3. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

    International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516

  4. Cognitive decline in Huntington's disease expansion gene carriers

    Cortex, Vol. 95, pp. 51-62